Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Carcinoma Medullary

Below is an extended Carcinoma Medullary research listing. Click here to return to the Carcinoma Medullary main in depth entry.

Recent Publications on Carcinoma Medullary:

Carcinoma of the breast with medullary-like features: diagnostic challenges and relationship with BRCA1 and EZH2 functions. 18th November, 2009
Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA.
Persistent hypercalcitoninemia in patients with medullary thyroid cancer. 18th November, 2009
Endocrine Surgical Unit, University of Perugia, Perugia, Italy.
Novel treatment of medullary thyroid cancer.
PURPOSE OF REVIEW: Metastatic medullary thyroid cancer (MTC) is an...
Direct Link
17th November, 2009
Endocrinology and Diabetes Division, Veterans Affairs Greater Los Angeles
Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.
BACKGROUND: About one quarter of all medullary thyroid cancers (MTC) are...
Direct Link
6th November, 2009
Department of Surgery I, Charite Medical School, Campus Benjamin Franklin,
Medullary thyroid carcinoma with poor differentiation and atypical radiographic pattern of metastasis.
A diagnosis of sporadic medullary thyroid carcinoma (MTC) is complicated....
Direct Link
30th October, 2009
Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital,
Undifferentiated gastric carcinoma with lymphoid stroma (lymphoepithelioma-like carcinoma/medullary carcinoma). 23rd October, 2009
Dipartimento di Patologia Umana ed Oncologia, Sezione Anatomia Patologica,
Thyroid cancer update: dramatic changes in the treatment of a rare disease. 17th October, 2009
Abramson Cancer Center, Department of Otorhinolaryngology, University of
Radioiodine-resistant differentiated thyroid cancer: hope for the future. 17th October, 2009
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania,
New directions in the systemic treatment of metastatic thyroid cancer. 17th October, 2009
The Johns Hopkins School of Medicine, Sidney Kimmel Comprehensive Cancer
Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone. 14th October, 2009
Department of Immuno-Endocrinological Pathology, San Martino University
Immunohistochemical expression of MAP1LC3A and MAP1LC3B protein in breast carcinoma tissues.
Autophagy is a protein degradation process within the cell and its...
Direct Link
7th October, 2009
Advanced Medical and Dental Institute, Universiti Sains Malaysia, Kepala
A patient with medullary thyroid carcinoma and right ventricular cardiac metastasis treated by (90)Y-Dotatoc. 2nd October, 2009
Department of Nuclear Medicine, Public Hospital of Brescia, Brescia,
Ratio of metalloproteinase 2 to tissue inhibitor of metalloproteinase 2 in medullary thyroid carcinoma.
OBJECTIVES: To develop an index for the ratio of metalloproteinase 2...
Direct Link
16th September, 2009
Surgery Department of the Universidade de Sao Paulo Medical School, Rua
Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.
OBJECTIVE: This study sought to define the need for lymph node dissection...
Direct Link
21st August, 2009
Department of General, Visceral and Vascular Surgery, Martin Luther
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.
PURPOSE: This phase II study investigated the efficacy and tolerability of...
Direct Link
21st August, 2009
Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex,

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.